VISTAGEN THERAPEUTICS, INC. Amortization of Deferred Leasing Fees
VISTAGEN THERAPEUTICS, INC. (VTGN) reported Amortization of Deferred Leasing Fees of $146.30 thousand for the 12-month period ending 2018-03-31, per its 10-K filed 2018-06-26.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AmortizationOfDeferredLeasingFees · last filed 2018-06-26
- VISTAGEN THERAPEUTICS, INC. amortization of deferred leasing fees for fiscal 2018 was $146.30K, a 74.79% increase from fiscal 2017.
- VISTAGEN THERAPEUTICS, INC. amortization of deferred leasing fees for fiscal 2017 was $83.70K.
- VISTAGEN THERAPEUTICS, INC. amortization of deferred leasing fees for fiscal 2016 was -$27.50K.
- VISTAGEN THERAPEUTICS, INC. amortization of deferred leasing fees for fiscal 2015 was -$14.40K.
| Period end | Amortization of Deferred Leasing Fees 12 month |
|---|---|
| 2018-03-31 | $146.30K 10-K · filed 2018-06-26 |
| 2017-03-31 | $83.70K 10-K · filed 2018-06-26 |
| 2016-03-31 | -$27.50K 10-K · filed 2017-06-29 |
| 2015-03-31 | -$14.40K 10-K · filed 2016-06-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |